Autologous Endothelial Progenitor Cells Transplantation for Chronic Ischemic Stroke
Status:
Completed
Trial end date:
2020-02-01
Target enrollment:
Participant gender:
Summary
Stroke is a frequently occurring and common diseases in nervous system,and most of the
survivors will remain disorders of motor,sensory and cognition function.Stem cell
transplantation provides a promising approach for rehabilitation. The main objective of this
study is to evaluate the efficacy and safy of the transplantation of autologous endothelial
progenitor cells in patients with chronic stroke.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Southern Medical University, China
Collaborator:
Second Affiliated Hospital of Guangzhou Medical University